Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J
Yes, GLP-1s have been used safely in women over 40, including those in perimenopause or menopause
36 Months : Weight loss becomes more noticeable, with most patients losing 510% of their body weight by this point
Reduced cravings for unhealthy foods, making it easier to maintain a balanced diet
SN : There has been research that suggests GLP-1 drugs might cause cancer
Furthermore, activity of critical neurotransmitter synthesis enzymes such as dopamine beta hydroxylase have been long known to be reduced in AD (Cross et al., 1981), which are also dependent on copper for its catalytic activity and would likewise be compromised by copper deficiency (Vendelboe et al., 2016)